Tecentriq (Atezolizumab) is an immune checkpoint inhibitor used for the treatment of certain types of cancer. It belongs to a class of monoclonal antibodies that enhance the immune system’s ability to detect and fight cancer cells.
Indications:
Non-small cell lung cancer (NSCLC).
Advanced or metastatic urothelial carcinoma (bladder cancer).
Other tumors as prescribed by a physician.
Key Features:
Boosts the immune system’s natural response to cancer.
Often used in advanced stages or in combination with other cancer therapies.
Administered under strict medical supervision.
Administration:
Administered via intravenous infusion (IV) in a clinical setting.
Dosage and duration are based on the type of cancer and patient condition.
Warnings & Precautions:
May cause immune-related side effects such as inflammation of the lungs, liver, intestines, or endocrine glands.
Organ function must be monitored throughout treatment.
Not recommended during pregnancy or breastfeeding unless directed by a healthcare provider.
Storage:
Store at 2–8°C (refrigerated).
Do not freeze. Use as directed after removal from refrigeration.
Reviews
There are no reviews yet.